AR192689A1 - Procedimiento de preparacion de sales aceptables farmaceuticamente de las aza-8 purinonas-6 sustituidas - Google Patents
Procedimiento de preparacion de sales aceptables farmaceuticamente de las aza-8 purinonas-6 sustituidasInfo
- Publication number
- AR192689A1 AR192689A1 AR245510A AR24551072A AR192689A1 AR 192689 A1 AR192689 A1 AR 192689A1 AR 245510 A AR245510 A AR 245510A AR 24551072 A AR24551072 A AR 24551072A AR 192689 A1 AR192689 A1 AR 192689A1
- Authority
- AR
- Argentina
- Prior art keywords
- purinones
- procedure
- pharmaceutically acceptable
- acceptable salts
- preparing pharmaceutically
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5955270 | 1970-12-15 | ||
| GB5955670 | 1970-12-15 | ||
| GB4975671A GB1338235A (en) | 1970-12-15 | 1971-10-26 | Azapurinones |
| GB5345771 | 1971-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR192689A1 true AR192689A1 (es) | 1973-02-28 |
Family
ID=27449009
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR239632A AR192602A1 (es) | 1970-12-15 | 1971-12-15 | Preparacion de aza-8 purinonas-6 sustituidas en 2 |
| AR245509A AR199468A1 (es) | 1970-12-15 | 1972-12-06 | Procedimiento de preparacion de aza-8 purinonas-6 sustituidas en 2 |
| AR245508A AR199467A1 (es) | 1970-12-15 | 1972-12-06 | Procedimiento de preparacion de aza-8 purinonas-6 sustituidas en 2 |
| AR245510A AR192689A1 (es) | 1970-12-15 | 1972-12-06 | Procedimiento de preparacion de sales aceptables farmaceuticamente de las aza-8 purinonas-6 sustituidas |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AR239632A AR192602A1 (es) | 1970-12-15 | 1971-12-15 | Preparacion de aza-8 purinonas-6 sustituidas en 2 |
| AR245509A AR199468A1 (es) | 1970-12-15 | 1972-12-06 | Procedimiento de preparacion de aza-8 purinonas-6 sustituidas en 2 |
| AR245508A AR199467A1 (es) | 1970-12-15 | 1972-12-06 | Procedimiento de preparacion de aza-8 purinonas-6 sustituidas en 2 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US3987160A (es) |
| JP (1) | JPS5310599B1 (es) |
| AR (4) | AR192602A1 (es) |
| AT (4) | AT315839B (es) |
| AU (1) | AU458277B2 (es) |
| BE (1) | BE776683A (es) |
| BG (3) | BG20807A3 (es) |
| CH (5) | CH552610A (es) |
| DD (1) | DD95007A5 (es) |
| DE (1) | DE2162096A1 (es) |
| DK (1) | DK141249B (es) |
| FI (1) | FI53457C (es) |
| FR (1) | FR2118078B1 (es) |
| GB (1) | GB1338235A (es) |
| HK (1) | HK42177A (es) |
| HU (1) | HU165079B (es) |
| IE (1) | IE35897B1 (es) |
| IL (1) | IL38364A (es) |
| IS (1) | IS1099B6 (es) |
| LU (1) | LU64457A1 (es) |
| NL (1) | NL174943C (es) |
| NO (1) | NO134257C (es) |
| OA (1) | OA03930A (es) |
| SE (1) | SE393381B (es) |
| ZM (1) | ZM18971A1 (es) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1493685A (en) * | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
| BE792648A (fr) * | 1971-12-13 | 1973-06-12 | May & Baker Ltd | Derives de l'isoquinoleine |
| FR2406638A1 (fr) * | 1977-10-21 | 1979-05-18 | May & Baker Ltd | Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant |
| EP0007727B1 (en) * | 1978-07-24 | 1983-11-30 | Beecham Group Plc | Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them |
| JPS60226887A (ja) * | 1984-04-25 | 1985-11-12 | Dai Ichi Seiyaku Co Ltd | トリアゾロピリミジン誘導体 |
| CA1303037C (en) * | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
| US5204353A (en) * | 1987-04-07 | 1993-04-20 | Ciba-Geigy Corporation | 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith |
| DE3873812D1 (de) * | 1987-04-07 | 1992-09-24 | Ciba Geigy Ag | 3h-1,2,3-triazolo(4,5-d)pyrimidine. |
| FR2618073B1 (fr) * | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
| GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
| DE4211239C2 (de) * | 1992-04-03 | 1995-11-16 | Max Planck Gesellschaft | Arzneimittel gegen Herz-Kreislauf-Erkrankungen |
| US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
| GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
| GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
| US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
| US6080428A (en) * | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
| US6129930A (en) * | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
| US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
| US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| US20080045573A1 (en) * | 1993-09-20 | 2008-02-21 | Bova David J | Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia |
| GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
| CH693954A5 (de) | 1997-11-12 | 2004-05-14 | Bayer Ag | 2-Phenyl-substituierte Imidazotriazinone als Phosphodiesterase Inhibitoren. |
| DE19838705A1 (de) * | 1998-08-26 | 2000-03-02 | Bayer Ag | Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one |
| IT1318674B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Faramaci per l'incontinenza. |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| JP5546451B2 (ja) | 2007-06-04 | 2014-07-09 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸の障害、炎症、癌および他の障害の処置に有用なグアニル酸シクラーゼのアゴニスト |
| EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| DK2681236T3 (en) | 2011-03-01 | 2018-04-16 | Synergy Pharmaceuticals Inc | PROCEDURE FOR MANUFACTURING GUANYLATE CYCLASE-C-AGONISTS |
| JP6499591B2 (ja) | 2013-02-25 | 2019-04-10 | シナジー ファーマシューティカルズ インコーポレイテッド | 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト |
| JP2016514671A (ja) | 2013-03-15 | 2016-05-23 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼのアゴニストおよびその使用 |
| EP2968439A2 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| EP4424697A2 (en) | 2013-06-05 | 2024-09-04 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
| EP3884935B1 (en) | 2013-08-09 | 2023-06-14 | Ardelyx, Inc. | Compounds and methods for inhibiting phosphate transport |
| BR112019012251A2 (pt) | 2016-12-14 | 2019-11-05 | Respira Therapeutics Inc | métodos e composições para tratamento de hipertensão pulmonar e outros distúrbios pulmonares |
| TWI845600B (zh) | 2019-01-24 | 2024-06-21 | 美商普羅米修斯生物科學股份有限公司 | Gpr35調節劑 |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
| WO2022020617A1 (en) * | 2020-07-23 | 2022-01-27 | Prometheus Biosciences, Inc. | Therapeutic agents targeting gpr35 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2407204A (en) * | 1944-07-22 | 1946-09-03 | American Cyanamid Co | Triazolo (d) pyrimidines and methods of preparing the same |
| US2993039A (en) * | 1959-11-06 | 1961-07-18 | Upjohn Co | Preparing nu-glycosides of aldose and ketose sugars |
-
1971
- 1971-10-26 GB GB4975671A patent/GB1338235A/en not_active Expired
- 1971-12-06 DK DK596371AA patent/DK141249B/da not_active IP Right Cessation
- 1971-12-14 CH CH222574A patent/CH552610A/fr not_active IP Right Cessation
- 1971-12-14 CH CH1853872A patent/CH546779A/fr not_active IP Right Cessation
- 1971-12-14 CH CH1823271A patent/CH555351A/fr not_active IP Right Cessation
- 1971-12-14 SE SE7116090A patent/SE393381B/xx unknown
- 1971-12-14 CH CH1853672A patent/CH550814A/fr not_active IP Right Cessation
- 1971-12-14 OA OA54440A patent/OA03930A/xx unknown
- 1971-12-14 FI FI3560/71A patent/FI53457C/fi active
- 1971-12-14 NL NLAANVRAGE7117142,A patent/NL174943C/xx not_active IP Right Cessation
- 1971-12-14 NO NO4614/71A patent/NO134257C/no unknown
- 1971-12-14 IS IS2047A patent/IS1099B6/is unknown
- 1971-12-14 CH CH1853772A patent/CH556860A/xx not_active IP Right Cessation
- 1971-12-14 FR FR7144869A patent/FR2118078B1/fr not_active Expired
- 1971-12-14 BE BE776683A patent/BE776683A/xx not_active IP Right Cessation
- 1971-12-14 AU AU36867/71A patent/AU458277B2/en not_active Expired
- 1971-12-14 JP JP10078571A patent/JPS5310599B1/ja active Pending
- 1971-12-14 ZM ZM189/71A patent/ZM18971A1/xx unknown
- 1971-12-14 IE IE1583/71A patent/IE35897B1/xx unknown
- 1971-12-14 HU HUMA2296A patent/HU165079B/hu unknown
- 1971-12-14 DD DD159572A patent/DD95007A5/xx unknown
- 1971-12-14 IL IL38364A patent/IL38364A/xx unknown
- 1971-12-14 LU LU64457D patent/LU64457A1/xx unknown
- 1971-12-14 DE DE19712162096 patent/DE2162096A1/de active Granted
- 1971-12-15 BG BG020380A patent/BG20807A3/xx unknown
- 1971-12-15 AT AT272473A patent/AT315839B/de not_active IP Right Cessation
- 1971-12-15 BG BG019250A patent/BG20805A3/xx unknown
- 1971-12-15 AT AT272273A patent/AT319235B/de not_active IP Right Cessation
- 1971-12-15 AT AT272373A patent/AT317211B/de not_active IP Right Cessation
- 1971-12-15 BG BG020379A patent/BG20806A3/xx unknown
- 1971-12-15 AT AT1075671A patent/AT315838B/de not_active IP Right Cessation
- 1971-12-15 AR AR239632A patent/AR192602A1/es active
-
1972
- 1972-12-06 AR AR245509A patent/AR199468A1/es active
- 1972-12-06 AR AR245508A patent/AR199467A1/es active
- 1972-12-06 AR AR245510A patent/AR192689A1/es active
-
1973
- 1973-05-29 US US05/364,425 patent/US3987160A/en not_active Expired - Lifetime
-
1977
- 1977-08-11 HK HK421/77A patent/HK42177A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR192689A1 (es) | Procedimiento de preparacion de sales aceptables farmaceuticamente de las aza-8 purinonas-6 sustituidas | |
| BG19802A3 (bg) | Метод за получаване на фенил-имидазолилалканилови производни | |
| SE384505B (sv) | Forfarande for framstellning av 2,4-diamino-5-bensylpyrimidinderivat | |
| SE397530B (sv) | Forfarande for framstellning av 1-pyrazolylalkyl-4-arylpiperazinderivat | |
| AR195314A1 (es) | Procedimiento para preparar derivados de piperidinoalcanol alfa-aril-4-sustituidos | |
| IT1013028B (it) | Procedimento per preparare maltitolo | |
| SE409209B (sv) | Forfarande for framstellning av n-acetyl-6,7-aziridino-6-desamino-7-deoxi-alfa-tiolinkosaminid-derivat | |
| FI49504C (fi) | Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi. | |
| SE387344B (sv) | Forfarande for framstellning av pyrazin-4-oxidderivat | |
| BE764252A (fr) | Procede pour la preparation de derives de quinoleine | |
| IT999554B (it) | Procedimento per preparare diacetossibutano | |
| SE380528B (sv) | Forfarande for framstellning av 2-klor-7-hydroxi-11-piperazinyldibensoxazepmderivat | |
| SE373572B (sv) | Forfarande for framstellning av pyroglutamyl-histidyl-prolinamid | |
| IT1033071B (it) | Procedimento per prepare tiazolsolfenammidi | |
| SE397518B (sv) | Forfarande for framstellning av 2-(n-mono-substituerade-amino)-fenylketonderivat | |
| SE386676B (sv) | Forfarande for framstellning av tropan-3-ol-derivat | |
| IT1050130B (it) | Procedimento per preparare orio solfobenzimmidi | |
| SE415974B (sv) | Forfarande for framstellning av 2-bensoyl-3-amino-pyridinderivat | |
| SE419441B (sv) | Forfarande for framstellning av butyrofenonderivat | |
| AR202397A1 (es) | Procedimiento para preparar derivados de metilendiamina sustituidos | |
| IT1050705B (it) | Procedimento per preparare aloge nociclopropani | |
| IT997899B (it) | Procedimento per preparare monoformil diamminomaleonitril | |
| IT942551B (it) | Metodo per preparare ditiobiureti sostituiti | |
| IT944763B (it) | Procedimento per preparare alchenil norborneni | |
| AR202774A1 (es) | Procedimiento para preparar derivados de 1,2,3,4,5,6-hexahidro 2,6-metano-3-benzazocina |